Equity (Details) - USD ($) |
1 Months Ended | 3 Months Ended | 12 Months Ended | |||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Feb. 09, 2021 |
Feb. 06, 2021 |
Jan. 27, 2021 |
Dec. 08, 2020 |
Nov. 03, 2020 |
Dec. 09, 2019 |
Nov. 13, 2019 |
Oct. 14, 2019 |
Oct. 03, 2019 |
Apr. 08, 2019 |
Jun. 07, 2018 |
Feb. 28, 2021 |
Sep. 17, 2020 |
Jul. 07, 2020 |
Jun. 30, 2020 |
Aug. 26, 2019 |
Jul. 22, 2019 |
Jul. 02, 2019 |
Mar. 31, 2017 |
Jan. 30, 2016 |
Sep. 30, 2020 |
Jun. 30, 2021 |
Jun. 30, 2020 |
Mar. 16, 2021 |
Nov. 02, 2020 |
Mar. 22, 2017 |
|
| Equity (Details) [Line Items] | ||||||||||||||||||||||||||
| Aggregate shares of common stock (in Shares) | 1,560,000 | |||||||||||||||||||||||||
| Cancellation of treasury shares (in Shares) | 35,099 | |||||||||||||||||||||||||
| Common stock, description | the Company effected a l-for-5 reverse stock split of its common stock in order to satisfy continued listing requirements of its common stock on the NASDAQ Capital Market. The reverse stock split was approved by the Company’s board of directors and stockholders and was intended to allow the company to meet the minimum share price requirement of $1.00 per share for continued listing on the NASDAQ Capital Market. As a result all common stock share amounts included in this filing have been retroactively reduced by a factor of five, and all common stock per share amounts have been increased by a factor of five. Amounts affected include common stock outstanding, including those that have resulted from the stock options, and warrants that convert to common stock. | |||||||||||||||||||||||||
| Warrants to purchase of common stock (in Shares) | 1,791,666 | |||||||||||||||||||||||||
| Offering cost | $ 1,430,000 | |||||||||||||||||||||||||
| Warrants exercise price (in Dollars per share) | $ 1.99 | |||||||||||||||||||||||||
| Warrants expire term | 5 years 6 months | |||||||||||||||||||||||||
| Common stock price per share (in Dollars per share) | $ 5.97 | |||||||||||||||||||||||||
| Common stock issued (in Shares) | 60,000 | 3,718,788 | 15,132,113 | 3,718,788 | ||||||||||||||||||||||
| Consecutive trading days | 20 days | |||||||||||||||||||||||||
| Purchase price (in Shares) | 3.10 | |||||||||||||||||||||||||
| Aggregate net proceeds | $ 26,100,000 | $ 12,400,000 | $ 4,836,000 | $ 52,772,977 | ||||||||||||||||||||||
| Exercise price (in Dollars per share) | $ 3.10 | |||||||||||||||||||||||||
| Term expire | 3 years 6 months | |||||||||||||||||||||||||
| Aggregate share of common stock (in Shares) | 3,655,000 | 1,998,500 | 1,086,956 | |||||||||||||||||||||||
| Purchase price for each share of common stock and warrants (in Dollars per share) | $ 3.68 | |||||||||||||||||||||||||
| Exercise price (in Dollars per share) | $ 5.00 | |||||||||||||||||||||||||
| Warrant exercise term, description | The Warrants will be exercisable at any time during the period beginning on or after July 27, 2021 and ending on or prior on January 27, 2026 but not thereafter; provided, however, that the total number of the Company’s issued and outstanding shares of Common Stock, multiplied by the NASDAQ official closing bid price of the Common Stock shall equal or exceed $0.3 billion for a three consecutive month period prior to an exercise. | |||||||||||||||||||||||||
| Common stock shall equal or exceed value | $ 300,000,000 | |||||||||||||||||||||||||
| Purchase price per shares (in Dollars per share) | $ 7.80 | $ 6.805 | ||||||||||||||||||||||||
| Common stock exercise price (in Dollars per share) | $ 7.80 | $ 6.805 | ||||||||||||||||||||||||
| Consulting fees | $ 140,556 | |||||||||||||||||||||||||
| Consulting services agreement , description | The scope of services primarily covers business consultation for one year from July 1, 2019 to June 30, 2020. The Company can terminate the agreement if they are not satisfy with the performance of the consulting firm and the consulting firm should return all the issued shares. | |||||||||||||||||||||||||
| Authorized grants, description | Included in a Board resolution dated January 30, 2016, the Company’s CEO is authorized to grant to the employees up to one million shares under the Company’s 2014 Stock Incentive Plan (the “Plan”). | |||||||||||||||||||||||||
| Common stock price per share (in Dollars per share) | ||||||||||||||||||||||||||
| Issuance of common stock | $ 1,427,600 | |||||||||||||||||||||||||
| Stock-based compensation expense | $ 1,576,756 | |||||||||||||||||||||||||
| 2014 Stock Incentive Plan [Member] | ||||||||||||||||||||||||||
| Equity (Details) [Line Items] | ||||||||||||||||||||||||||
| Common stock issued (in Shares) | 50,000 | 50,000 | ||||||||||||||||||||||||
| Fair value of common stock | $ 152,500 | |||||||||||||||||||||||||
| Compensation expense | $ 152,500 | |||||||||||||||||||||||||
| Common stock price per share (in Dollars per share) | $ 3.05 | $ 3.05 | ||||||||||||||||||||||||
| Restricted Stock [Member] | ||||||||||||||||||||||||||
| Equity (Details) [Line Items] | ||||||||||||||||||||||||||
| Compensation expense | $ 432,000 | |||||||||||||||||||||||||
| Restricted common shares (in Shares) | 18,000 | 120,000 | ||||||||||||||||||||||||
| Restricted common shares fair value | $ 63,000 | $ 432,000 | ||||||||||||||||||||||||
| Restricted per share value (in Dollars per share) | $ 3.50 | |||||||||||||||||||||||||
| Cooperation Agreement [Member] | ||||||||||||||||||||||||||
| Equity (Details) [Line Items] | ||||||||||||||||||||||||||
| Aggregate shares of common stock (in Shares) | 200,000 | |||||||||||||||||||||||||
| Purchase price per share (in Dollars per share) | $ 5.00 | |||||||||||||||||||||||||
| Aggregate proceeds | $ 1,000,000.0 | |||||||||||||||||||||||||
| Received proceeds | 940,131 | |||||||||||||||||||||||||
| Remaining proceeds | $ 59,869 | |||||||||||||||||||||||||
| Securities Purchase Agreements [Member] | ||||||||||||||||||||||||||
| Equity (Details) [Line Items] | ||||||||||||||||||||||||||
| Aggregate shares of common stock (in Shares) | 1,170,000 | 230,000 | 720,000 | |||||||||||||||||||||||
| Service Agreements [Member] | ||||||||||||||||||||||||||
| Equity (Details) [Line Items] | ||||||||||||||||||||||||||
| Issuance of common stock shares (in Shares) | 80,000 | |||||||||||||||||||||||||
| Fair value of common stock | $ 508,000 | |||||||||||||||||||||||||
| Consulting services agreement , description | The scope of services primarily covers legal consultation in PRC during the two-year service period from July 2018 to June 2020. The consulting entity is entitled to be granted the common stock on a quarterly basis in eight equal installments. | |||||||||||||||||||||||||
| Compensation expense | 254,000 | |||||||||||||||||||||||||
| Issuance of common stock | $ 300,000 | |||||||||||||||||||||||||
| Remuneration for services | $ 222,000 | |||||||||||||||||||||||||
| Service Agreements [Member] | Consulting and Advisory Services ;[Member] | ||||||||||||||||||||||||||
| Equity (Details) [Line Items] | ||||||||||||||||||||||||||
| Compensation expense | 222,000 | |||||||||||||||||||||||||
| Consulting Services Agreement [Member] | ||||||||||||||||||||||||||
| Equity (Details) [Line Items] | ||||||||||||||||||||||||||
| Consulting services agreement , description | the Company entered into a consulting services agreement with a consulting entity, which provides management consulting and advisory services. The scope of services primarily covered advising on business development, strategic planning and compliance during the six months service period from April 8, 2019 to October 7, 2019. The Company issued 60,000 shares of common stock as remuneration for the services, which were issued as restricted shares at $4.25 per share on April 16, 2019 to the consulting entity. These shares were valued at $255,000. | |||||||||||||||||||||||||
| Compensation expense | 127,500 | |||||||||||||||||||||||||
| Service Contract [Member] | ||||||||||||||||||||||||||
| Equity (Details) [Line Items] | ||||||||||||||||||||||||||
| Common stock issued (in Shares) | 8,000 | |||||||||||||||||||||||||
| Fair value of common stock | $ 28,800 | |||||||||||||||||||||||||
| Compensation expense | 28,800 | |||||||||||||||||||||||||
| Common stock price per share (in Dollars per share) | $ 3.60 | |||||||||||||||||||||||||
| Consultants [Member] | ||||||||||||||||||||||||||
| Equity (Details) [Line Items] | ||||||||||||||||||||||||||
| Common stock issued for services, shares (in Shares) | 50,000 | |||||||||||||||||||||||||
| Restricted share price (in Dollars per share) | $ 12.65 | |||||||||||||||||||||||||
| Restricted common stock value issued | 632,500 | |||||||||||||||||||||||||
| Chief Executive Officer [Member] | ||||||||||||||||||||||||||
| Equity (Details) [Line Items] | ||||||||||||||||||||||||||
| Compensation expense | 63,000 | |||||||||||||||||||||||||
| Series A Convertible Preferred Stock [Member] | ||||||||||||||||||||||||||
| Equity (Details) [Line Items] | ||||||||||||||||||||||||||
| Warrants price per share (in Dollars per share) | $ 1.66 | |||||||||||||||||||||||||
| Aggregate issued shares (in Shares) | 860,000 | |||||||||||||||||||||||||
| Warrants to purchase of common stock (in Shares) | 1,032,000 | |||||||||||||||||||||||||
| Preferred stock conversion (in Shares) | 860,000 | |||||||||||||||||||||||||
| Warrant [Member] | ||||||||||||||||||||||||||
| Equity (Details) [Line Items] | ||||||||||||||||||||||||||
| Aggregate shares of common stock (in Shares) | 1,998,500 | |||||||||||||||||||||||||
| Purchase price per share (in Dollars per share) | $ 156,400 | $ 1.46 | ||||||||||||||||||||||||
| Purchase of warrants (in Shares) | 0.68 | 720,000 | ||||||||||||||||||||||||
| Net proceeds | $ 1,050,000.00 | |||||||||||||||||||||||||
| Warrants price per share (in Dollars per share) | $ 1.825 | |||||||||||||||||||||||||
| Description of warrant rights | The warrants will expire on March 16, 2026. The warrants are subject to anti-dilution provisions to reflect stock dividends and splits or other similar transactions. The warrants contain a mandatory exercise right for the Company to force exercise the warrants if the Company’s common stock trades at or above $4.38 for 20 consecutive trading days, provided, among other things, that the shares issuable upon exercise of the are registered or may be sold pursuant to Rule 144 and the daily trading volume exceeds 60,000 shares of common stock per trading day on each trading day in a period of 20 consecutive trading days prior to the applicable date. | |||||||||||||||||||||||||
| Aggregate net proceeds | 4,800,000 | |||||||||||||||||||||||||
| Aggregate share of common stock (in Shares) | 3,655,000 | 5,434,780 | ||||||||||||||||||||||||
| Net proceeds of offering | $ 4,000,000.0 | |||||||||||||||||||||||||
| Exercised warrants to purchase shares | $ 317,869 | |||||||||||||||||||||||||
| Compensation expense | $ 156,400 | |||||||||||||||||||||||||
| Warrant [Member] | Common Stock [Member] | ||||||||||||||||||||||||||
| Equity (Details) [Line Items] | ||||||||||||||||||||||||||
| Common stock issued (in Shares) | 1,532,869 | |||||||||||||||||||||||||
| Common Stock [Member] | ||||||||||||||||||||||||||
| Equity (Details) [Line Items] | ||||||||||||||||||||||||||
| Preferred stock conversion (in Shares) | 860,000 | |||||||||||||||||||||||||
| Issuance of common stock | ||||||||||||||||||||||||||